U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute (NYSE:PFE ...

Retrieved on: 2022-03-08 05:33:33

Tags for this article:

COVID-19 vaccination in the United States

Clinical trials

RNA vaccines

COVID-19 pandemic by country

Joe Biden

Presidency of Joe Biden

SARS-CoV-2 Omicron variant

AbCellera

Click the tags to see associated articles and topics

U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute (NYSE:PFE .... View article details on hiswai:

Excerpt

... oral antivirals, and monoclonal antibodies, testing, and also global vaccination ... Developers of COVID-19 antibody therapies: Eli Lilly (LLY ...

Article found on: seekingalpha.com

View Original Article